We are live on ! Find out more
BDSX icon

Biodesix

40 hedge funds and large institutions have $10M invested in Biodesix in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.61% less ownership

Funds ownership: 1.83%1.21% (-0.61%)

32% less funds holding

Funds holding: 5940 (-19)

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

70% less capital invested

Capital invested by funds: $33.4M → $10M (-$23.3M)

76% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 25

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
40
Holders Change
-19
Holders Change %
-32.2%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
6
Increased
7
Reduced
12
Closed
25
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Corient Private Wealth
26
Corient Private Wealth
Florida
$16.6K
VPIM
27
Vanguard Personalized Indexing Management
California
$11.8K +$16.9K +2,095 New
CIBC Private Wealth Group
28
CIBC Private Wealth Group
Georgia
$8.28K
TRCT
29
Tower Research Capital (TRC)
New York
$8.09K +$9.99K +1,238 +635%
SM
30
Samjo Management
New York
$7.05K -$972K -120,405 -99%
CSS
31
Cubist Systematic Strategies
Connecticut
$4.05K +$5.79K +717 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$3.95K
CIC
33
Carnegie Investment Counsel
Ohio
$2.82K +$4.04K +500 New
Cetera Investment Advisers
34
Cetera Investment Advisers
Illinois
$2.82K +$4.04K +500 New
Morgan Stanley
35
Morgan Stanley
New York
$361 -$4.68K -580 -90%
Bank of America
36
Bank of America
North Carolina
$212 +$57 +7 +23%
Barclays
37
Barclays
United Kingdom
$51 -$22.3K -2,763 -100%
Citigroup
38
Citigroup
New York
$22 -$1.85K -229 -98%
Fidelity Investments
39
Fidelity Investments
Massachusetts
$8
UBS Group
40
UBS Group
Switzerland
$6 -$597 -74 -99%
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$2
ACM
42
AIGH Capital Management
Maryland
-$2.67M -213,630 Closed
OM
43
Opaleye Management
Massachusetts
-$2.02M -161,250 Closed
Wells Fargo
44
Wells Fargo
California
-$513K -40,995 Closed
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
-$375K -29,971 Closed
Renaissance Technologies
46
Renaissance Technologies
New York
-$232K -18,535 Closed
Millennium Management
47
Millennium Management
New York
-$209K -16,698 Closed
Squarepoint
48
Squarepoint
New York
-$88.7K -7,092 Closed
Marshall Wace
49
Marshall Wace
United Kingdom
-$55.5K -4,406 Closed
Qube Research & Technologies (QRT)
50
Qube Research & Technologies (QRT)
United Kingdom
-$42.5K -3,395 Closed

BDSX Hedge Fund Activity: Q2 2025 in Review

40 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q2 2025, worth a combined $10M — down 70% from $33.4M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of BDSX and 6 opened new positions — a net loss of 19 holders — while 12 trimmed existing stakes and 7 added.

The largest buyer was GSA Capital Partners, adding an estimated $363K. The largest seller was AIGH Capital Management, exiting entirely with an estimated $2.67M sold.

  • 40 institutional investors held Biodesix (BDSX) as of Q2 2025, down from 59 in Q1 2025.
  • Funds reported $10M of Biodesix stock for Q2 2025, down 70% quarter-over-quarter.
  • 6 funds opened new Biodesix positions in Q2 2025 and 25 closed out, a net change of -19 holders.
  • The largest Biodesix buyer in Q2 2025 was GSA Capital Partners, an estimated $363K added.
  • The largest Biodesix seller in Q2 2025 was AIGH Capital Management, an estimated $2.67M sold.

Based on aggregated 13F filings for Q2 2025.